MED
MED 1-star rating from Upturn Advisory

MEDIFAST INC (MED)

MEDIFAST INC (MED) 1-star rating from Upturn Advisory
$11.04
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/26/2025: MED (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $15

1 Year Target Price $15

Analysts Price Target For last 52 week
$15 Target price
52w Low $10.36
Current$11.04
52w High $18.59

Analysis of Past Performance

Type Stock
Historic Profit -39.98%
Avg. Invested days 20
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/26/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 121.34M USD
Price to earnings Ratio 552
1Y Target Price 15
Price to earnings Ratio 552
1Y Target Price 15
Volume (30-day avg) 1
Beta 0.5
52 Weeks Range 10.36 - 18.59
Updated Date 12/27/2025
52 Weeks Range 10.36 - 18.59
Updated Date 12/27/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.02

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 0.06%
Operating Margin (TTM) -4.56%

Management Effectiveness

Return on Assets (TTM) 1.52%
Return on Equity (TTM) 0.12%

Valuation

Trailing PE 552
Forward PE -
Enterprise Value -39907347
Price to Sales(TTM) 0.28
Enterprise Value -39907347
Price to Sales(TTM) 0.28
Enterprise Value to Revenue -
Enterprise Value to EBITDA 0.05
Shares Outstanding 10991273
Shares Floating 9167019
Shares Outstanding 10991273
Shares Floating 9167019
Percent Insiders 3.2
Percent Institutions 86.12

About MEDIFAST INC

Exchange NYSE
Headquaters Baltimore, MD, United States
IPO Launch date 1993-12-31
Executive Chairman & CEO Mr. Daniel R. Chard
Sector Consumer Cyclical
Industry Personal Services
Full time employees 504
Full time employees 504

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.